Rodis JF, Quinn DL, Gary GW, Anderson LJ, Rosengren S, Cartter ML, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol. 1990;163(4):1168–71.
Gratacós E, Torres P-J, Vidal J, Antolín E, Costa J, de Anta MTJ, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis. 1995;171(5):1360–3.
Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. BJOG. 1998;105(2):174–8.
Article
CAS
Google Scholar
Cioc AM, Sedmak DD, Nuovo GJ, Dawood MR, Smart G, Magro CM. Parvovirus B19 associated adult Henoch Schönlein purpura. J Cutan Pathol. 2002;29(10):602–7.
Article
PubMed
Google Scholar
White FV, Jordan J, Dickman PS, Knisely A. Fetal parvovirus B19 infection and liver disease of antenatal onset in an infant with Ebstien's anomaly. Fetal Pediatr Pathol. 1995;15(1):121–9.
CAS
Google Scholar
Simchen MJ, Toi A, Bona M, Alkazaleh F, Ryan G, Chitayat D. Fetal hepatic calcifications: prenatal diagnosis and outcome. Am J Obstet Gynecol. 2002;187(6):1617–22.
Article
PubMed
Google Scholar
Heegaard ED, Petersen BL, Heilmann CJ, Hornsleth A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol. 2002;40(3):933–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sukanya T, Pilaiwan K, Rattana K, Pakaphan K, Junya J, Thawlwong R. Hydrops fetalis caused by parvovirus B19 infection case report and literature. J Med Assoc Thail. 2006;89:1277–68.
Google Scholar
Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J. 1987;6(8):711–8.
Article
CAS
PubMed
Google Scholar
Mossong J, HENS N, Friederichs V, Davidkin I, Broman M, Litwinska B, et al. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect. 2008;136(08):1059–68.
Röhrer C, Gärtner B, Sauerbrei A, Böhm S, Hottenträger B, Raab U, et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect. 2008;136(11):1564–75.
Ergaz Z, Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol. 2006;21(4):421–35.
Article
CAS
PubMed
Google Scholar
Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol. 1998;91(3):413–20.
Article
CAS
PubMed
Google Scholar
Enders M, Weidner A, Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect. 2007;135(04):563–9.
Article
CAS
PubMed
Google Scholar
Crane J. Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can. 2002;24(9):727–43. quiz 744–726
Article
PubMed
Google Scholar
Emiasegen SE, Nimzing L, Adoga MP, Ohagenyi AY, Lekan R. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria. Mem Inst Oswaldo Cruz. 2011;106(2):227–31.
Article
PubMed
Google Scholar
Schwarz T, Gürtler L, Zoulek G, Deinhardt F, Roggendorf M. Seroprevalence of human parvovirus B19 infection in Sao Tome and Principe, Malawi and Mascarene Islands. Zentralblatt für Bakteriologie. 1989;271(2):231–6.
Article
CAS
PubMed
Google Scholar
Abiodun I, Opaleye OO, Ojurongbe O, Fagbami AH. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo state, Nigeria. J Infect Dev Ctries. 2013;7(12):946–50.
Article
PubMed
Google Scholar
Schoub B, Blackburn N, Johnson S, McAnerney J. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa. S Afr Med J. 1993;83(7):505–6.
CAS
PubMed
Google Scholar
Elnifro E, Nisha A, Almabsoot M, Daeki A, Mujber N, Muscat J. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya. J Infect Dev Ctries. 2009;3(03):218–20.
Article
PubMed
Google Scholar
Butchko AR, Jordan JA. Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J Clin Microbiol. 2004;42(7):3191–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hannachi N, Marzouk M, Harrabi I, Ferjani A, Ksouri Z, Ghannem H, et al. Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia. Bull Soc Pathol Exot. 2011;104(1):62–7.
Ma M, Pacsa A, Essa SS, Ahmed MA, Monem RA, Surkouh M. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait. Acta Trop. 1999;73(3):225–9.
Article
Google Scholar
Eskild A, Jeansson S, Hagen J, Jenum P, Skrondal A. Herpes simplex virus type-2 antibodies in pregnant women: the impact of the stage of pregnancy. Epidemiol Infect. 2000;125(03):685–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
BABOONIAN C, GRIFFITHS P. Is pregnancy immunosuppressive? Humoral immunity against viruses. BJOG Int J Obstet Gynaecol. 1983;90(12):1168–75.
Article
CAS
Google Scholar
AMINO N, TANIZAWA O, MIYAI K, TANAKA F, HAYASHI C, KAWASHIMA M, et al. Changes of serum immunoglobulins IgG, IgA, IgM, and IgE during pregnancy. Obstet Gynecol. 1978;52(4):415–20.
Barros DFR, Buarque DGS, Durigon EL, Linhares AC. Survey of parvovirus B19 infection in a cohort of pregnant women in Belem, Brazil. Braz J Infect Dis. 1999;3(1):6–14.
Google Scholar